Background illustration for clinical trials search

Paid Clinical Trials Florida

Discover 3,824 paid clinical trials in Florida. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

Assessment of Comfort Level Following an Intravitreal Injection by 30 or 32 Gauge Needles

for
Pain
Location: Fort Myers FL
Sponsor: Retina Health Center

Sex: All

Age: 0+

Code: NCT02142114

Early_phase1, Recruiting

Rapid Evacuation and Access of Cerebral Hemorrhage Trial

for
Stroke Hemorrhagic
Location: Providence RI, Albany NY, Baltimore MD, Syracuse NY,
Sponsor: Emory University

Sex: All

Age: 18 - 70

Code: NCT06870812

Recruiting

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

for
Prostate Cancer (Adenocarcinoma)
Location: Saint John, Providence RI, Saint Johnsbury VT,
Sponsor: Canadian Cancer Trials Group

Sex: Male

Age: 18+

Code: NCT06592924

Phase3, Recruiting

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

for
Solid Tumor Cancer, Locally Advanced, Metastatic Solid Tumors,
Location: Washington D.C. DC, Sarasota FL, Atlanta GA, Houston TX,
Sponsor: Avenzo Therapeutics, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07038343

Phase1, Phase2, Recruiting

WISE-2B Brain Study (Weight Loss Intervention Surgical Effects on Brain Function)

for
Diabetes, Weight Loss
Location: Gainesville FL
Sponsor: University of Florida

Sex: All

Age: 20 - 70+

Code: NCT06861790

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Magnetic Resonance Imaging and Biomarkers for Muscular Dystrophy

for
Duchenne Muscular Dystrophy, Becker Muscular Dystrophy
Location: Gainesville FL, Portland OR
Sponsor: University of Florida

Sex: Male

Age: 5 - 62

Code: NCT01484678

Recruiting

Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma

for
Hepatocellular Carcinoma
Location: New Haven CT, Quebec, New York NY, New Brunswick NJ,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06921785

Phase3, Recruiting

Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)

for
Acute Decompensated Heart Failure
Location: Stony Brook NY, Philadelphia PA, Richmond VA,
Sponsor: Reprieve Cardiovascular, Inc

Sex: All

Age: 22+

Code: NCT06898515

Phase3, Recruiting

Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients

for
PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, NSCLC,
Location: Boston MA, New York NY, Washington D.C. DC, Fairfax VA,
Sponsor: Tango Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06922591

Phase1, Phase2, Recruiting

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

for
Recurrent Non-Muscle Invasive Bladder Carcinoma,
Location: Peabody MA, Boston MA, Burlington MA, Commack NY,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT07000084

Phase3, Recruiting

Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET

for
Somatostatin Receptor Positive (SSTR+),
Location: Hartford CT, New Haven CT, New York NY, Montreal,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 12 - 70+

Code: NCT06784752

Phase3, Recruiting

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

for
Systemic Lupus Erythematosus (With and Without Nephritis),
Location: New York NY, East Brunswick NJ, Montreal, Durham NC,
Sponsor: Allogene Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07085104

Phase1, Recruiting

A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis

for
Systemic Sclerosis (SSc)
Location: Philadelphia PA, Baltimore MD, Columbia MD,
Sponsor: argenx

Sex: All

Age: 18+

Code: NCT06655155

Phase2, Recruiting

Perspectives on Spinal Manipulative Therapy for Low Back Pain

for
Low Back Pain
Location: Gainesville FL
Sponsor: University of Florida

Sex: All

Age: 18 - 70

Code: NCT06590116

Recruiting

RETRO Study (RETrograde Renal Access Outcomes)

for
Renal Stones
Location: Tampa FL, Kansas City KS
Sponsor: University of Kansas Medical Center

Sex: All

Age: 18+

Code: NCT07071831

Recruiting

EyeConic: Qualification for Cone-Optogenetics

for
Retinal Dystrophies
Location: Miami FL, Pittsburgh PA, San Francisco CA
Sponsor: Institute of Molecular and Clinical Ophthalmology Basel

Sex: All

Age: 0+

Code: NCT05294978

Recruiting

A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China

for
Hyperphosphatemia, Chronic Kidney Disease, Receiving Dialysis,
Location: Orange CT, Ridgewood NY, Cheektowaga NY, Fort Myers FL,
Sponsor: Alebund Pharmaceuticals

Sex: All

Age: 12+

Code: NCT06933472

Phase3, Recruiting

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

for
Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis,
Location: Boston MA, Providence RI, New York NY, Glen Burnie MD,
Sponsor: Spyre Therapeutics, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07012395

Phase2, Recruiting

A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)

for
Malignant Neoplasm
Location: Boston MA, Valhalla NY, New York NY, New Brunswick NJ,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 0 - 17

Code: NCT06941272

Phase1, Phase2, Recruiting

Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study

for
Moderate Aortic Valve Stenosis
Location: Boston MA, Quebec, The Bronx NY, Albany NY, Montreal,
Sponsor: Kardigan, Inc.

Sex: All

Age: 50+

Code: NCT07001800

Phase2, Phase3, Recruiting

Popular cities in Florida

Florida is one of the country’s top states for life sciences and clinical research thanks to its diverse healthcare infrastructure, top talent, and renowned medical research institutions. Major institutions like the University of Florida Health, the Sylvester Comprehensive Cancer Center, and Mayo Clinic Florida are at the forefront of cutting-edge research and clinical studies.

Florida's broad demographic diversity enhances the validity of clinical research, offering a wide range of participants that contribute to more comprehensive study results. This makes Florida a top location for clinical trials, ensuring advancements in treatments are both innovative and highly relevant.

Why choose Florida for clinical trials?

Florida presents unique advantages for those participating in clinical trials. The state's diverse and growing population ensures a wide variety of participants, enhancing the accuracy and relevance of research outcomes. Florida is also recognized for its cutting-edge medical research institutions, with a strong focus on innovative healthcare advancements and groundbreaking clinical studies.

By participating in a clinical trial in Florida, individuals contribute to vital medical research while benefiting from a well-established and supportive clinical research system, making the state an ideal location for advancing medical knowledge and improving healthcare.

Common conditions studied in Florida

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Florida